9.44
-0.44
(-4.45%)
At close: 5:28:58 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 1 | 1 |
Avg. Estimate | 0 | 0 | 0.32 | 0.58 |
Low Estimate | 0 | 0 | 0.32 | 0.58 |
High Estimate | 0 | 0 | 0.32 | 0.58 |
Year Ago EPS | -- | -- | 0.41 | 0.32 |
Revenue Estimate
Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 2 | 2 |
Avg. Estimate | -- | -- | 211.35M | 229M |
Low Estimate | -- | -- | 210.4M | 227.2M |
High Estimate | -- | -- | 212.3M | 230.8M |
Year Ago Sales | -- | -- | 203.6M | 211.35M |
Sales Growth (year/est) | -- | -- | 3.81% | 8.35% |
EPS Trend
Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0.32 | 0.58 |
7 Days Ago | 0 | 0 | 0.37 | 0.72 |
30 Days Ago | 0 | 0 | 0.58 | 0.77 |
60 Days Ago | 0 | 0 | 0.58 | 0.77 |
90 Days Ago | 0 | 0 | 0.58 | 0.77 |
EPS Revisions
Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | 1 | 1 |
Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
LBIRD.PA | -- | -- | -22.52% | 81.25% |
S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Related Tickers
ALPRE.PA Predilife S.A.
4.0800
-6.42%
LZAGF Lonza Group AG
588.11
-3.27%
BIM.PA bioMérieux S.A.
110.20
+3.77%
BDSX Biodesix, Inc.
1.2400
-2.36%
DIA.MI DiaSorin S.p.A.
101.60
-1.17%
MYGN Myriad Genetics, Inc.
14.39
-2.97%
ERF.PA Eurofins Scientific SE
49.05
-0.04%
STIM Neuronetics, Inc.
1.8000
+5.26%
NEOG Neogen Corporation
12.58
+1.78%
VCYT Veracyte, Inc.
42.27
+1.75%